Indegene Introduces TrialPedia 2.0 with ‘Advantage Insights’, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
ISELIN, New Jersey, August 20, 2012 /PRNewswire/ –
Indegene Inc. (http://www.indegene.com), a leading global pharmaceutical and
healthcare solutions provider, today announced the launch of TrialPedia 2.0 with Advantage
Insights for clinical trial analytics and decision support.
The number of drugs approved by the USFDA over the years has been declining, and is
testament to the difficulties pharmaceutical companies continue to face to drive revenues.
As companies grapple with shrinking pipelines, stricter safety and regulatory
requirements, and spiraling costs to bring products to the marketplace, the need for
clinical trial analytics is paramount.
TrialPedia 2.0, a proprietary platform offered by Indegene, helps Clinical Development
and Operations, R&D, Competitive Intelligence (CI), BD & Licensing, as well as Strategic
Marketing professionals effectively analyze clinical literature and trial data seamlessly,
and benchmark competitive Clinical Development Programs (CDPs) across the industry.
TrialPedia provides quick and comprehensive answers to strategic clinical development and
marketing questions including market evolution, competitive label claims, licensing
options, and future sales projections. It includes industry leading features such as
therapy area specific query parameters, claim space prediction tools, trial feasibility,
operations analysis, and identification of competitive differentiators. TrialPedia 2.0
combines over 300 man-years of effort in assimilating knowledge to build a comprehensive
Clients can further enhance the value of TrialPedia via Advantage Insights – a service
bureau that is designed to enhance the business value of clinical trial analytics and help
clients comprehensively research, study, monitor, report, and derive insights from the
global clinical trial landscape. In this model, Indegene leverages TrialPedia and its
expertise to perform analysis and reporting on behalf of the client. Clients can also
avail of custom research and analysis through bundled Analyst Hours Support.
Manish Gupta, CEO – Indegene said “With Advantage Insights, in addition to clients
gaining access to TrialPedia 2.0, they can leverage our deep research and analytics
expertise for all their reporting and analysis needs. We believe that this will enable
clients to navigate the business environment more effectively and with greater
Indegene is a leading provider of R&D, commercial and marketing solutions to global
pharmaceutical and healthcare organizations. We partner with clients to drive both
productivity and revenues by delivering better patient outcomes, optimizing cost,
enhancing R&D agility, and improving sales and marketing effectiveness. We apply deep
scientific knowledge, flexible delivery models, proprietary technology, and a
client-centric approach to drive transformational initiatives. To learn more about
Indegene, visit us at http://www.indegene.com.
For further information contact: US and Europe Ann Marie Craggan Indegene Inc. Phone: +1-732-750-2901 Email: email@example.com APAC Sherin Varghese Genesis Burson-Marsteller Mobile: +91-99161-15584 Email: firstname.lastname@example.org
SOURCE Indegene Lifesystems Pvt Ltd